Join to View Full Profile
1365 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-2020
Fax+1 404-778-5059
Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Ophthalmology, 2008 - 2011
University of Rochester Medical CenterResidency, Internal Medicine, 2007 - 2008
Duke University School of MedicineClass of 2007
Certifications & Licensure
OR State Medical License 2014 - Present
GA State Medical License 2014 - 2026
MI State Medical License 2012 - 2016
NC State Medical License 2008 - 2015
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Reply to Comment on "Pentosan Polysulfate Maculopathy: Final Outcomes From a 4-Year Prospective Study of Disease Progression After Drug Cessation".Brian P Hall, Sakshi Shiromani, Emily H Jung, Riley J Lyons, Judith Tribe
American Journal of Ophthalmology. 2025-03-11 - Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation.Brian P Hall, Sakshi Shiromani, Emily H Jung, Riley J Lyons, Judith Tribe
American Journal of Ophthalmology. 2025-03-01 - Reduced retinal microvascular density in women with coronary microvascular dysfunction: A pilot study.Sakshi Shiromani, Ahmed AlBadri, Aaron Lindeke-Myers, Arielle Schwartz, Nishant Vatsa
American Heart Journal Plus. 2025-03-01
Journal Articles
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJoseph M Simonett, Mark E Pennesi, Nieraj Jain, JAMA Ophthalmology
Authored Content
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
Press Mentions
Treatment for Stargardt Disease May Be CloseJanuary 21st, 2025- FDA Approves Light Therapy for Dry AMDJanuary 21st, 2025
- Presumed Rubber Bullet Ocular TraumaJuly 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
